ALTO Ingredients (NASDAQ: ALTO) insider transactions
In the twelve months to 10 November 2026, executives and directors of ALTO Ingredients reported 0 open-market sales and 4 open-market purchases of 85,000 shares ($361,250), by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 14 September 2026 | Nathan Gilbert E | Director | Open-market purchase | +10,000 | $3.93 | 866,393 | Form 4 |
| 11 August 2026 | Nathan Gilbert E | Director | Open-market purchase | +50,000 | $4.15 | 856,393 | Form 4 |
| 23 June 2026 | Gray Maria G | Director | Grant or award | +23,605 | — | 179,229 | Form 4 |
| 23 June 2026 | Tank Alan Robert | Director | Grant or award | +23,605 | — | 60,271 | Form 4 |
| 23 June 2026 | Nathan Gilbert E | Director | Grant or award | +31,652 | — | 806,393 | Form 4 |
| 23 June 2026 | Nury Dianne S. | Director | Grant or award | +23,605 | — | 241,015 | Form 4 |
| 14 May 2026 | Graham Auste M | CLO & Secretary | Gift | −20,000 | — | 233,173 | Form 4 |
| 13 May 2026 | Nathan Gilbert E | Director | Open-market purchase | +5,000 | $4.45 | 774,741 | Form 4 |
| 12 May 2026 | Nathan Gilbert E | Director | Open-market purchase | +20,000 | $4.61 | 769,741 | Form 4 |
| 1 April 2026 | Graham Auste M | CLO & Secretary | Shares withheld for tax | −32,902 | $4.79 | 253,173 | Form 4 |
| 1 April 2026 | McGregor Bryon T | President & CEO | Shares withheld for tax | −73,062 | $4.79 | 957,882 | Form 4 |
| 1 April 2026 | Sneed James R | Chief Commercial Officer | Shares withheld for tax | −22,265 | $4.79 | 440,926 | Form 4 |
| 1 April 2026 | Olander Robert R. | Chief Financial Officer | Shares withheld for tax | −41,072 | $4.79 | 253,086 | Form 4 |
| 1 April 2026 | Benton Todd E | COO | Shares withheld for tax | −25,359 | $4.79 | 184,130 | Form 4 |
| 17 March 2026 | McGregor Bryon T | President & CEO | Grant or award | +100,108 | — | 1,030,944 | Form 4 |
| 17 March 2026 | Graham Auste M | CLO & Secretary | Grant or award | +30,794 | — | 286,075 | Form 4 |
| 17 March 2026 | Olander Robert R. | Chief Financial Officer | Grant or award | +35,730 | — | 294,158 | Form 4 |
| 17 March 2026 | Sneed James R | Chief Commercial Officer | Grant or award | +30,794 | — | 463,191 | Form 4 |
| 17 March 2026 | Benton Todd E | COO | Grant or award | +35,730 | — | 209,489 | Form 4 |
| 13 August 2025 | Sneed James R | Chief Commercial Officer | Open-market purchase | +3,176 | $1.06 | 432,397 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the ALTO Ingredients page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.